Navigation Links
VaxGen Addresses MPM Claims in Letter to Stockholders
Date:12/20/2007

Seeks to Correct the Record and Provide Accurate Information to

Stockholders

SOUTH SAN FRANCISCO, Calif., Dec. 20 /PRNewswire-FirstCall/ -- VaxGen, Inc. (Pink Sheets: VXGN)

(Logo: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO)

Dear Stockholder:

As you are aware, VaxGen and Raven biotechnologies announced on November 12, 2007 that their respective Boards of Directors had unanimously approved the merger of the two companies, subject to stockholder approval.

As you may also have seen, MPM BioEquities Advisors, a VaxGen stockholder, sent a letter to me and VaxGen's Board on December 11, 2007. The content of this letter was subsequently disclosed by MPM in a press release on December 12th. We believe that this letter and press release contain errors, misstatements and incorrect assumptions which MPM has used to support its recommendation that VaxGen terminate the proposed merger, place its assets into a holding company, and pursue the sale or distribution of those assets; i.e., liquidation. The primary purpose of my letter to you is to correct the record, and to ensure that all stockholders have the necessary, accurate information in order to make an informed decision regarding the proposed merger. I also want to take the opportunity to comment on a number of issues that have arisen in my many conversations with stockholders over the last month.

MPM's analysis appears to reflect errors of three kinds:

1. It relies on very aggressive, indeed unrealistic, valuations of the

Company's non-financial assets, especially in a liquidation scenario,

and ignores the extensive process the Company and its advisors have

already undertaken over this past year seeking to monetize these

assets.

2. It fails to take full account of VaxGen's liabilities a
'/>"/>

SOURCE VaxGen
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. VaxGen Files 2006 Financial Statements and Provides Cash Update
2. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
3. VaxGen Files First Quarter 2007 Financials
4. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
5. VaxGen Files Last Outstanding Periodic Report With SEC
6. Free White Paper Addresses Challenges of New FDA Regulations Awaiting Combo Product Manufacturers
7. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
8. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
9. Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics
10. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
11. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/8/2008)...man to Lead Scientific Operations, NAPLES, Fla., ...rs of,DIRECT TO ETHANOL(TM), the most advanced thi... the appointment of Dr. John R. Coleman as Chief,S...incipal Research and,Graduate Studies at the Unive...in the fields of molecular biology and biochemistr...
(Date:9/8/2008)...ept. 8 /Xinhua-- BMP,Sunsto...e "Company") today,announced that the Company will...ond Annual Beijing Management Summit, held at the ...08. The Company is scheduled to present at 10:2... event. Investors interested in attending this ev...
(Date:9/8/2008)... 8 /- Don Margolis, Chairman of,The R...epairStemCells.org ) based in,Bangkok, Thailand to...ve,news interview published today that future prof...ard to come by over the next five years, even for,... called "adult stem,cells"), where new life scienc...
(Date:9/8/2008)... Data to be Presented at the 7th International ...ZURICH, Switzerland, Sept. 8 /- ESBAT...herapeutics, today announced that the,company has ...of the,company,s lead product candidate, ESBA105, ... initiated the Phase I study designed to evaluate ...
Breaking Biology Technology:Algenol Biofuels Appoints Chief Science Officer 2BMP Sunstone Announces Participation in September Investor Conference 2Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript 2ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications 2
... rights against potential infringers by licensing ...infringing activity. Thanks to a recent Federal Ci... practice. , ,Typically, the patent owner would do...ing that a party agree to pay for a license and th...ing proposals carried little risk of triggering un...
...bott Laboratories story regarding its Kaletra AID...iland over patent protection and drug pricing. Som...tiff between a single drug company and another dev...ral - if not the central - problem facing the ...ed - regard this to be one of the most important i...
...Supreme Court strengthened the case against stem ... Foundation? , ,The answer is yes, according to th...s challenging the patents, but that,s not necessar...t, in a strong rebuke to the U.S. Court of Appeal...International Corp. in KSR International v. Te...
...n-Madison faculty members Sean Carroll and Laura ... National Academy of Sciences . , ,Election to the... honors bestowed upon American scientists. Carroll...nd Kiessling, a professor of chemistry and biochem...nts and ongoing contributions to original research...
Other Biology Technology:Patent licensing: For enforcing companies, the rules have changed 2Patent licensing: For enforcing companies, the rules have changed 3Abbott vs. Thailand has implications for innovation and access 2Abbott vs. Thailand has implications for innovation and access 3Abbott vs. Thailand has implications for innovation and access 4Abbott vs. Thailand has implications for innovation and access 5Abbott vs. Thailand has implications for innovation and access 6Abbott vs. Thailand has implications for innovation and access 7Supreme Court ruling seen as blow to WARF stem cell patents 2Supreme Court ruling seen as blow to WARF stem cell patents 3
(Date:9/5/2008)...euroinformatics will convene September 7-9 at the ... emerging neuroinformatics field combines neurosci...tools and approaches to understanding the structur... applied to brain disorders and diseases. With a b...g together experts from all disciplines contributi...
(Date:9/5/2008)...imals face the challenge of surviving in a changin...and Universit Claude Bernard Lyon have shown how a...coast of Scotland responds to two consequences of ...unpredictability of winter storms. Dr. Thomas Ezar... are good and food is plentiful, lambs contribute ...
(Date:9/5/2008)...th of Hurricane Gustav is shown via a sequence of ...lution Imaging Spectrometer (MERIS) instrument on ...08 (from right to left). , Gustav formed on 25 A..., Haiti (seen above far right image), when a tropi... eye feature (visible), causing the U.S. National ...
(Date:9/4/2008)...the M.D. Anderson Cancer Center have developed a r...ally for African Americans that suggests a greater...COPD), according to a report published in the Sept...rnal of the American Association for Cancer Resear...91 African Americans with lung cancer and 497 Afri...
Breaking Biology News(10 mins):INCF organizes the first congress dedicated to the emerging field of neuroinformatics 2Hurricane Gustav 2African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease 2Anti TGF Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma Malignant Melanoma and Colorec 2285 1Anti TGF Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma Malignant Melanoma and Colorec 2285 2Anti TGF Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma Malignant Melanoma and Colorec 2285 3Anti TGF Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma Malignant Melanoma and Colorec 2285 4Weizmann Institute scientists develop a new approach to treating autoimmune disease 20822 1Weizmann Institute scientists develop a new approach to treating autoimmune disease 20822 2Notice of Initial Distribution of Net Settlement Funds 5733 1Notice of Initial Distribution of Net Settlement Funds 5733 2Notice of Initial Distribution of Net Settlement Funds 5733 3Blocking signaling protein prevents prostate cancer spread Jefferson scientists find 20819 1Blocking signaling protein prevents prostate cancer spread Jefferson scientists find 20819 2
...ervices University of the Health Sciences (USU) su...e that protects against the myriad strains of the ...ive vaccine may need to stimulate the body to prod... multiple viral strains. These results demonstrate...ng antibodies may be an achievable goal. This grou...
...chronic lung disease typically characterized by th...h or cough. Most patients live about five years af...eing published today in the online journal PLoS ON...ofile has a much more rapid progression to complet...plant. , Based on observations in the clinic that ...
...ing out for other mothers, kids. , An intriguing...y the University of Alberta in Edmonton, Canada an...owed that both species responded to the recorded d...licited when coyotes attack fawns, with mule deer ... calls, even when their own fawn stood next to the...
...ctive method for revealing anatomical details of s...e images even clearer and allow physiological proc...dolinium complexes currently used as MRI contrast ...ed in the journal Angewandte Chemie, Korean resear...r and Taeghwan Hyeon at Seoul National University ...
Other Biology News:Gene expression patterns predict rapid decline in idiopathic pulmonary fibrosis patients 2Mule deer moms rescue other fawns 2
...ant SpeedVac™ Concentrators set the standard...c' series SC210A SpeedVac with large chamber uses ...m to dry multiple samples in a single run. , SC210...or Chamber for long lasting chemical compatibilit...
Digital display of time, vacuum and temperature , Dual vacuum control of ramping rate and ultimate level , Comes complete with RH40-12 (40 x 1.5 ml) Rotor and (2) Glass Condensation Flasks.
...RC10 series of vacuum concentrators/centrifugal ev...n features allied to rapid and safe concentration ...mbined with oil-free or high vacuum pumps, a choic...iminating sample loss by transfer), ensuring solve...
...inos Affiliation: School of Psychology, The Univer... Watson Affiliation: Curtin University of Technolo... this definitive atlas of the rat brain. It is a ...xtension of the compact 3rd edition. This product...
Biology Products: